HLA-B*0801-binding EBV peptide

Description: HLA-B*0801-bindingEBV peptide, derived from the Epstein-Barr virus (EBV) epitope FLRGRAYGL, interacts with the HLA-B*0801 molecule. This peptide is presented to CD8+ T cells via HLA-B*0801, thereby activating a specific immune response. Target: Others. Smiles: [C@@H](CC1=CC=C(O)C=C1)(NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC([C@@H](NC([C@H](CC2=CC=CC=C2)N)=O)CC(C)C)=O)CCCNC(=N)N)=O)=O)CCCNC(=N)N)=O)C)=O)C(NCC(N[C@@H](CC(C)C)C(O)=O)=O)=O